By Jonathan Stempel NEW YORK (Reuters) -Bristol Myers Squibb won the dismissal of a proposed class action accusing it of ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.

Opioid settlements with companies like Purdue Pharma, Walmart, and Johnson & Johnson have led to headline-grabbing ...

Teva Pharma (TEVA) stock gains as the company and Samsung Bioepis launch Epysqli, a biosimilar to AstraZeneca's (AZN) rare ...

Teva Pharmaceuticals (TEVA) and Samsung Bioepis (SSNLF) announced the availability of EPYSQLI in the U.S. EPYSQLI is a biosimilar to Soliris ...

Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted its supplemental Biologics License Application ...

Analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of Teva Pharmaceutical Industries in a ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other stocks that Jim Cramer discussed 12 months ago. During the latest ...

Deep-pocketed investors have adopted a bullish approach towards Teva Pharmaceutical Indus (NYSE:TEVA), and it's something market players shouldn't ignore. Our tracking of public options records at ...

The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry Logistics Network Ltd on March 11, further bolstering the pharmaceutical ...